Patents/Assignees

Neuracle Science Co., Ltd.

15 patents in portfolio

US12492246utility2025
Anti-fam19a5 Antibodies and Uses Thereof
0 cites
US12492244utility2025
Anti-family with Sequence Similarity 19, Member A5 Antibodies and Method of Use Thereof
0 cites
US12466880utility2025
Use of Anti-family with Sequence Similarity 19, Member A5 Antibodies for the Treatment of Glaucoma
0 cites
US12459995utility2025
Use of Anti-fam19a5 Antibodies
0 cites
US12435130utility2025
Pharmaceutical Use of FAM19A5 Involved in Regulating Gliogenesis
0 cites
US12247070utility2025
Use of Anti-fam19a5 Antibodies for Treating Atherosclerosis
0 cites
US12202889utility2025
Anti-family with Sequence Similarity 19, Member A5 Antibodies and Method of Use Thereof
0 cites
US12077579utility2024
Use of Anti-fam19a5 Antibodies for Treating Fibrosis
0 cites
US12072339utility2024
Use of Anti-family with Sequence Similarity 19, Member A5 Antibodies for the Treatment and Diagnosis of Mood Disorders
0 cites
US11970532utility2024
Anti-family with Sequence Similarity 19, Member A5 Antibodies and Method of Use Thereof
0 cites
US11746149utility2023
Use of Anti-family with Sequence Similarity 19, Member A5 Antibodies for the Treatment of Glaucoma
0 cites
US11739141utility2023
Pharmaceutical Use of FAM19A5 Involved in Regulating Gliogenesis
0 cites
US11634484utility2023
Use of Anti-family with Sequence Similarity 19, Member A5 Antibodies for the Treatment of Neuropathic Pain
0 cites
US11618783utility2023
Anti-fam19a5 Antibodies and Uses Thereof
0 cites
US11560425utility2023
Use of Anti-fam19a5 Antibodies for Treating Cancers
0 cites